
Sign up to save your podcasts
Or


Send us a text
The Accelerators Podcast hosts Dr. Simul Parikh and Dr. Matt Spraker invite Radiation Oncologist Dr. Mudit Chowdhary on the show to discuss the recently released, controversial study of Enzalutamide monotherapy versus active surveillance for low or intermediate-risk localized prostate cancer.
Our discussion of this study dovetails in to other related topics including conflicts of interest with the pharmaceutical industry and hype for early phase studies.
Podcast art generously donated by Dr. Danielle Cunningham.
By The Accelerators4.5
3636 ratings
Send us a text
The Accelerators Podcast hosts Dr. Simul Parikh and Dr. Matt Spraker invite Radiation Oncologist Dr. Mudit Chowdhary on the show to discuss the recently released, controversial study of Enzalutamide monotherapy versus active surveillance for low or intermediate-risk localized prostate cancer.
Our discussion of this study dovetails in to other related topics including conflicts of interest with the pharmaceutical industry and hype for early phase studies.
Podcast art generously donated by Dr. Danielle Cunningham.

154,156 Listeners

38 Listeners

87,320 Listeners

2,439 Listeners

203 Listeners

61 Listeners

26,663 Listeners